Pieter Bothma

ORCID: 0000-0003-3822-204X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular and Diving-Related Complications
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Long-Term Effects of COVID-19
  • Restraint-Related Deaths
  • Airway Management and Intubation Techniques
  • Respiratory Support and Mechanisms
  • Sepsis Diagnosis and Treatment
  • Diabetic Foot Ulcer Assessment and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Tracheal and airway disorders
  • High Altitude and Hypoxia
  • Acute Ischemic Stroke Management
  • Congenital Diaphragmatic Hernia Studies
  • COVID-19 and healthcare impacts
  • Pneumothorax, Barotrauma, Emphysema
  • Abdominal Surgery and Complications
  • Hip and Femur Fractures
  • Nosocomial Infections in ICU
  • Peripheral Artery Disease Management
  • COVID-19 and Mental Health
  • Intensive Care Unit Cognitive Disorders
  • COVID-19 Impact on Reproduction
  • Antibiotic Use and Resistance

James Paget University Hospital
2012-2024

James Paget University Hospitals NHS Foundation Trust
2009-2024

Whipps Cross University Hospital
2014-2023

St Mary's Hospital
2023

International Severe Acute Respiratory and Emerging Infection Consortium
2023

The Queen's Medical Research Institute
2022

Centre for Inflammation Research
2022

University of Edinburgh
2022

Roslin Institute
2022

University College London Hospitals NHS Foundation Trust
2020

10.1016/s0140-6736(18)32521-2 article EN The Lancet 2019-04-25

Intravascular haemolysis is a rare but serious complication of Clostridium perfringens sepsis. The outcome usually fatal unless treatment started early. We describe case survival after and multiple organ failure in the setting ruptured liver abscess sepsis caused by C. an immunocompetent 58-year-old male.

10.1177/0310057x1003800522 article EN Anaesthesia and Intensive Care 2010-09-01

We studied anthrax immune globulin intravenous (AIG-IV) use from a 2009-2010 outbreak of Bacillus anthracis soft tissue infection in injection drug users Scotland, UK, and we compared findings 15 AIG-IV recipients with 28 nonrecipients. Death rates did not differ significantly between nonrecipients (33% vs. 21%). However, whereas only 8 (27%) 30 patients at low risk for death (admission sequential organ failure assessment score 0-5) received AIG-IV, 7 (54%) the 13 high (sequential 6-11)...

10.3201/eid2301.160608 article EN cc-by Emerging infectious diseases 2016-12-14

A man in his 30s presented with a brief episode of vomiting, acute abdominal pain and subsequent development shortness breath. On initial examination investigation, the clinical impression was right-sided pneumothorax, pneumonia pleural effusion. Early antibiotic treatment management showed improvement, patient reporting resolution symptoms. This short lived, further deterioration condition worsening Ensuing examination, imaging investigations demonstrated an oesophageal leak into right...

10.1136/bcr-2012-006485 article EN BMJ Case Reports 2012-06-22

To evaluate the Springfusor® infusion device for clinical use in an Intensive Care Unit and to compare technique of intermittent bolus constant muscle relaxants, we undertook a prospective double-blind randomized placebo-controlled study. Twenty critically ill ventilated patients requiring paralysis were investigated. Although could show no advantage infusing vecuronium, provided more level compared with hourly doses. The is robust, easy reduces nursing workload. This may translate into...

10.1177/0310057x9402200514 article EN Anaesthesia and Intensive Care 1994-10-01

Objectives Admission of patients with necrotising otitis externa (NOE) has been rising steadily over the last five years and mortality morbidity associated disease is high. Our objective to assess value adjuvant hyperbaric oxygen therapy in externa. Design setting A retrospective, observational, case-control study was conducted by examining patients’ records a four-and-a-half-year period at two secondary care sites UK. The (Non-HBO) control group treated conventionally (HBO) additional HBO...

10.22541/au.170665374.42767455/v1 preprint EN Authorea (Authorea) 2024-01-30
Coming Soon ...